Comments
Paring initial gains, shares of Shasun Pharmaceuticals shed 5 per cent on profit-booking today, despite the company reporting a growth in consolidated net profit for the fourth quarter ended March 31, 2012.
Even after a robust opening and touching a 52-week high, the scrip failed to hold the gains and lost 5 per cent to Rs 124.65 on the BSE from yesterday’s closing level.
The stock opened at a premium of about 3 per cent and soon touched a one-year high of Rs 136.80. Similarly, on the NSE, the scrip fell 5 per cent to Rs 124.65.
The scrip had rallied in the last five trading sessions.
Shasun Pharmaceuticals had yesterday reported a 53.57 per cent rise in consolidated net profit at Rs 58.99 crore for the fourth quarter ended March 31, 2012.
The company had posted a net profit of Rs 38.41 crore during the same period of previous fiscal, 2010—11.
Meanwhile, the Sensex was trading 81.71 points lower at 16,140.59.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.